Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelarabine in CTCL and PTCL
NCT00005080Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2000
- Primary completion
- Jan 2006
- Modality
- Prodrugs/Conditional Activator Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of nelarabine in cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), sponsored by National Cancer Institute. Started May 2000; status: completed.
02
Drugs
nelarabine
03
Conditions
cutaneous T-cell lymphoma (CTCL)peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT00005080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005080.